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Abstract
Background: Termination of translation in eukaryotes requires two release factors, eRF1, which
recognizes all three nonsense codons and facilitates release of the nascent polypeptide chain, and
eRF3 stimulating translation termination in a GTP-depended manner. eRF3 from different
organisms possess a highly conservative C region (eRF3C), which is responsible for the function in
translation termination, and almost always contain the N-terminal extension, which is inessential
and vary both in structure and length. In the yeast Saccharomyces cerevisiae the N-terminal region
of eRF3 is responsible for conversion of this protein into the aggregated and functionally inactive
prion form.
Results: Here, we examined functional importance of the N-terminal region of a non-prion form
of yeast eRF3. The screen for mutations which are lethal in combination with the SUP35-C allele
encoding eRF3C revealed the sup45 mutations which alter the N-terminal domain of eRF1 and
increase nonsense codon readthrough. However, further analysis showed that synthetic lethality
was not caused by the increased levels of nonsense codon readthrough. Dominant mutations in
SUP35-C were obtained and characterized, which remove its synthetic lethality with the identified
sup45 mutations, thus indicating that synthetic lethality was not due to a disruption of interaction
with proteins that bind to this eRF3 region.
Conclusion: These and other data demonstrate that the N-terminal region of eRF3 is involved
both in modulation of the efficiency of translation termination and functioning of the eRF1/eRF3
complex outside of translation termination.
Background
Termination of protein synthesis takes place in ribosomes
in a response to stop codons in the "decoding" site. The
proteins that control this process are called polypeptide
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chain release factors (RFs). In eubacteria there are two
class 1 polypeptide chain release factors, RF1 and RF2, rec-
ognizing UAA/UAG and UAA/UGA stop codons, respec-
tively, whereas eukaryotes employ only one such factor,
eRF1, which is able to decode all three nonsense codons
[1]. In addition, translation termination in eubacteria and
eukaryotes is stimulated by class 2 release factors, RF3 and
eRF3, respectively. Both class 2 factors are GTPases
enhancing the termination efficiency by stimulating activ-
ity of class 1 release factors in a GTP-dependent manner
[2-4]. RF3 is able to remove RF1 or RF2 from the ribosome
after hydrolysis of the ester bond in peptidyl tRNA, i.e. to
stimulate recycling of class 1 factors [5]. In contrast to
eubacterial RF3, eukaryotic eRF3 functions in termination
by applying its GTPase activity to assist eRF1 with the stop
codon recognition and/or ensures rapid and efficient
hydrolysis of peptidyl tRNA [6]. Importantly, this was
shown upon the excess of eRF1 when quantitative peptide
release did not require recycling of eRF1. In the yeast Sac-
charomyces cerevisiae eRF1 and eRF3 are encoded by the
essential SUP45 and SUP35 genes, and often designated
as Sup45p and Sup35p, respectively [3].
Members of the eRF1 family have been identified in a
number of eukaryotes and they all show a high degree of
sequence similarity. Determination of the crystal structure
of human eRF1 has shown that it is composed of three
domains and resembles by overall shape and dimensions
a tRNA molecule with the N-terminal and middle
domains corresponding to the tRNA's anticodon stem and
aminoacyl acceptor stem, respectively [7]. eRF3 also has a
complex structure and can be divided into at least two
regions: a non-conserved N-terminal region and a con-
served C-terminal region, showing a considerable
sequence similarity to the translation elongation factor
eEF1A, which brings aminoacyl-tRNAs to the ribosomal A
site. The C-terminal part (domain C) of the S. cerevisiae
eRF3 is responsible for the function of the protein in
translation termination. The N-terminal region of yeast
eRF3 is non-essential for the translation termination and
viability and may be further subdivided into the N-termi-
nal (N) domain, which was shown to be required for
maintenance of the cytoplasmically-inherited prion deter-
minant [PSI+] [8,9] and the middle (M) domain, which
also is important for [PSI+] propagation [10,11]. The non-
sense suppressor phenotype of [PSI+] reflects eRF3 aggre-
gation and functional inactivation [12,13]. Thus, the N
domain of eRF3 may inhibit translation termination in S.
cerevisiae in a [PSI+] prion-dependent manner. However,
other data have shown that this domain also affects func-
tion of a non-prion form of yeast eRF3, since deletion of
the eRF3 N-terminal extension (N and M domains)
decreased nonsense codon readthrough caused by deple-
tion of eRF1 [14]. This agrees with the results showing that
N-terminal extension of the Schizosaccharomyces pombe
eRF3 may inhibit translation termination by blocking
eRF1 binding to eRF3 [15]. However, the N-terminal
region of eRF3 from the filamentous fungus Podospora
anserina confers quite opposite effect on translation termi-
nation, since deletion of this protein region caused sup-
pression of nonsense mutations [16]. The effects of N-
terminal truncation of eRF3 have a species-specific charac-
ter probably because of the lack of sequence similarity
between the N-terminal regions of eRF3 homologs from
different organisms. Nevertheless, despite of structural
dissimilarity, the N-terminal regions of eRF3 from yeast
and mammals are able to interact with poly(A)+ binding
protein PABP, which probably serves for coupling termi-
nation and initiation steps of translation [17,18] and for
regulation of mRNA deadenylation and decay [19]. The
N-terminal region of S. cerevisiae eRF3 also is able to bind
other proteins, such as Itt1p, a protein with unknown
function, and Sla1p assisting in the cytoskeleton assembly
[20,21]. These interactions may modulate translation ter-
mination efficiency and link translation with other cellu-
lar processes.
Biochemical studies of S. cerevisiae eRF3 are hampered by
its propensity to aggregate [22,23]. This makes genetic
approach preferable to investigate function of this release
factor. Here, we identified mutations which alter eRF1
and make the N-terminal region of eRF3 indispensable.
The study of these mutations and their lethal interaction
with the SUP35 deletion allele, encoding the eRF3 C-ter-
minal domain, indicate the role of N-terminal region of
this factor in non-translational function of the eRF1/eRF3
termination complex in yeast.
Results
Identification and characterization of mutants in which 
deletion of the eRF3 NM region is lethal
The  SUP35-C  strain YJV159-rS35C carrying the pHT-
SUP35 (SUP35 ADE3) centromeric plasmid was muta-
genized with UV irradiation and over 150,000 of grown
colonies were screened using a yeast colony color sector-
ing assay. Among them, 23 were of Sect- phenotype. Such
clones could arise due to mutations in the SUP35-C gene,
since it is essential [8], or due to mutations in other genes.
To discriminate between these possibilities, the centro-
meric pRS315-SUP35C (SUP35-C LEU2) plasmid was
introduced into the YJV159-rS35C strain carrying pHT-
SUP35. In 22 cases this restored Sect+ phenotype indicat-
ing that mutations were within SUP35-C and correspond-
ing mutants were discarded. One mutant, which
segregated white sectors very poorly, preserved its leaky
Sect- phenotype in the presence of the pRS315-SUP35C
plasmid. The mutant, designated as YJV-rS35C-SL23,
could not grow at 37°C on YPD plate. This mutant carry-
ing pHT-SUP35 was transformed with a genomic library
based on the LEU2 centromeric plasmid p366, and twoBMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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transformants able to grow at non-permissive tempera-
ture were selected. The obtained temperature resistant
transformants were characterized by the frequent loss of
pHT-SUP35 at permissive temperature, thus being Sect+.
Plasmid from one transformant was isolated and partial
sequencing of the cloned DNA fragment has shown that it
contained the SUP45 gene. Subsequent delimitation of
the functional region of the isolated DNA fragment indi-
cated that SUP45 was responsible for both temperature
resistance and Sect+ phenotype. Transformation of this
mutant with various SUP45-carrying plasmids caused the
same effects. Thus, mutation that made the NM region of
eRF3 indispensable arose in the SUP45 gene. Transforma-
tion of the mutant YJV-rS35C-SL23 carrying pHT-SUP35
with the multicopy plasmid YEplac181-SUP35NM encod-
ing the eRF3 NM region did not restore the Sect+ pheno-
type. This indicated that expression of the entire eRF3
protein is necessary for viability of this mutant.
The obtained sup45 mutation, designated as sup45-sl23ts,
caused growth inhibition in the strain YJV-rS35C-SL23,
but was lethal in other sup45-sl23ts strains with the SUP35-
C allele. For example, the URA3 SUP35 plasmid pRS316-
SUP35 of the SUP35-disrupted strain 33G-D373-rSL23-
ΔS35 carrying sup45-sl23ts could not be replaced with the
LEU2 SUP35-C plasmids upon incubation on 5FOA
medium (Fig. 1). It is also important that in this strain the
plasmid pRS316-SUP35 also could not be replaced with
the centromeric pRS315-SUP35MC plasmid, encoding
eRF3 which lacks only the N domain (Fig. 1). Thus, just
the absence of the eRF3 prion-forming domain was
responsible for synthetic lethality.
Synthetic lethality was also reproduced in the S1-R-H8
strain. This strain, carrying SUP35-C, was disrupted for
SUP45 and contained the URA3 SUP45 centromeric plas-
mid pRG415-SUP45, which could not be replaced with
the plasmid pRS315-sup45-sl23 carrying the mutant
sup45-sl23ts allele. In contrast, in the control strain S1-H8
with chromosomal wild type SUP35, pRS315-sup45-sl23
could replace the resident pRG415-SUP45 plasmid. The
lethal effect of combination with SUP35-C was also found
for another sup45 mutation, sup45-36ts [24]: the pRS315-
sup45-36 plasmid did not replace pRG415-SUP45 in the
S1-R-H8 strain, but replaced this plasmid in the SUP45
disruptant S1-H8 bearing the wild type SUP35 gene.
The possible reason of lethality manifested by the sup45
mutations in combination with SUP35-C is the decreased
level of eRF1. However, the amount of eRF1 was not
affected in the sup45-36ts [25] and sup45-sl23ts mutants
(data not shown). S. cerevisiae eRF1 and eRF3 interact with
each other through the binding sites located at their C-ter-
mini [26,27], though the eRF3 N-terminal region also
may be involved in this interaction [28]. Mutations in
eRF1 breaking its interaction with eRF3 decrease cell via-
bility [27]. The observed disparity in genetic interaction of
the sup45-sl23ts and sup45-36ts mutations with SUP35 and
SUP35-C suggests that these mutations influence binding
of eRF1 to eRF3, and this effect is more pronounced when
eRF3 lacks its N-terminal region. However, the study of
the ability of Escherichia coli-expressed His6-eRF1 and
His6-eRF1-sl23 immobilized on TALON beads to precipi-
tate eRF3 and eRF3C from yeast cell lysates [27] did not
show a noticeable effect of sup45-sl23ts mutation on the
interaction of eRF1 with both eRF3 and eRF3C (data not
shown).
The sup45-sl23ts and sup45-36ts mutations altered the eRF1
N domain (Ser-30 to Phe and Leu-34 to Ser substitutions,
respectively), increased nonsense codon readthrough and
caused temperature sensitivity [25]. At elevated tempera-
ture corresponding mutations did not cause any noticea-
ble increase in the levels of nonsense codon readthrough
(Fig. 2 and data not shown), but affected cell morphology.
The sup45-36ts mutation caused defect of cytokinesis and
resulted in appearance of multinucleated cells with elon-
gated buds. The defect of cytokinesis in this mutant is
related to mislocalization of the myosin light chain Mlc1p
and its temperature sensitivity could be suppressed by
Mlc1p overproduction [25]. In contrast, temperature sen-
sitivity of the sup45-sl23ts mutant could not be alleviated
by excess of Mlc1p. Cells of the sup45-sl23ts mutant were
increased in size (Fig. 3) and contained single nuclei (data
not shown). Temperature sensitivity of the sup45-sl23ts
The sup45-sl23ts mutation is lethal in the strain 33G-D373- rSL23-ΔS35, carrying the SUP35-C or SUP35-MC alleles Figure 1
The sup45-sl23ts mutation is lethal in the strain 33G-D373-
rSL23-ΔS35, carrying the SUP35-C or SUP35-MC alleles. The 
LEU2 plasmids with SUP35-C or SUP35-MC can not replace 
the resident URA3 plasmid pRS316-SUP35 carrying wild type 
SUP35 in the strain 33G-D373-rSL23-ΔS35. Transformants 
were incubated on 5FOA-containing medium for 3 days. Plas-
mids: SUP35-C, pRS315-SUP35C; SUP35-MC, pRS315-
SUP35MC; SUP35, pRS315-SUP35; empty vector, pRS315.BMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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Extra copies of sup45-sl23ts improve growth of the strain 33G-D373-rSL23 carrying the chromosomal sup45-sl23ts mutation at  37°C (A), but do not influence nonsense codon readthrough (B) Figure 2
Extra copies of sup45-sl23ts improve growth of the strain 33G-D373-rSL23 carrying the chromosomal sup45-sl23ts mutation at 
37°C (A), but do not influence nonsense codon readthrough (B). Empty vector, YEplac181; multi-sup45-sl23, YEplac181-sup45-
sl23. Photos were taken after incubation of transformants on leucine omission medium for 4 days. The strain 33G-D373-rSL23 
carrying the plasmids indicated above, was transformed with either one of the pUKC815, 817, 818, 819 plasmids and grown in 
medium selective for plasmids to mid log phase. Then appropriate aliquots of yeast culture were taken and β-galactosidase 
activity was assayed. Suppression efficiency (average from three independent transformants, each in three parallels) was esti-
mated as described [44].BMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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mutant can not be explained by a defect of translation ter-
mination, since increase of the number of sup45-sl23ts cop-
ies allowed mutant to grow at 37°C, but did not decrease
the levels of nonsense codon readthrough either at per-
missive or non-permissive temperature (Fig. 2). It is also
noteworthy that extra copies of the sup45-sl23ts allele did
not restore viability of the strain YJV-rS35C-SL23 carrying
chromosomal sup45-sl23ts and SUP35-C, indicating that
temperature sensitivity and synthetic lethality were caused
by the impairment of different cellular processes.
Mutations in SUP35-C abolishing its synthetic lethality 
with sup45-sl23ts or sup45-36ts
Mutations in SUP35-C which make it compatible with
sup45-sl23ts were obtained by passing the corresponding
plasmid in the E. coli "mutator" strain. Five independent
pools of the mutagenized plasmid were obtained and
used to transform the strain YJV-rS35C-SL23 which car-
ried the chromosomal sup45-sl23ts and SUP35-C  alleles
and the centromeric SUP35 ADE3 pHT-SUP35 plasmid.
Over 100,000 of transformed cells were incubated on leu-
cine omission medium at 37°C and 116 Leu+ temperature
resistant clones were selected. Streaking of these trans-
formants on leucine omission medium showed that 75 of
them produced colonies with Sect+ phenotype. The plas-
mid DNA from 8 Sect+ transformants was isolated and
used for repeated transformation of the strain YJV-rS35C-
SL23 carrying pHT-SUP35. All Leu+ transformants bearing
the isolated plasmids were temperature resistant and able
to lose the resident pHT-SUP35 (SUP35 ADE3 URA3)
plasmid on medium supplemented with uracil, suggest-
ing that they carried mutant SUP35-C. It is noteworthy
that, since these mutations were dominant, they restored
the normal growth rate and temperature resistance of the
sup45-sl23ts mutant YJV-rS35C-SL23 carrying the chromo-
somal SUP35-C allele. These SUP35-C mutant alleles sup-
ported viability of the sup45-sl23ts  mutant 33G-D373-
rSL23-ΔS35 disrupted for SUP35 and allowed its growth
at non-permissive temperature, indicating that suppres-
sion of temperature sensitivity did not depend on genetic
background.
Sequencing of the mutant SUP35-C alleles revealed that
they had nucleotide substitutions that caused either Glu-
539 to Lys (five cases, isolated from four mutagenized
plasmid pools), Ala-596 to Val (two cases, both derived
from the same plasmid pool) or Ala-597 to Val (one case)
replacements. It is noteworthy that these amino acid sub-
stitutions occurred in the positions located downstream
to the eRF3 regions implicated in GTP hydrolysis [3,8].
The corresponding alleles were respectively designated as
SUP35-C14, SUP35-C11 and SUP35-C42.
The isolated compensatory SUP35-C  mutations were
studied for the ability to alleviate temperature sensitivity
caused by the sup45-36ts mutant allele as well as to sup-
press its synthetic lethality with SUP35-C. Introduction of
either one of the plasmids with the SUP35-C14, SUP35-
C11 or SUP35-C42 alleles into the sup45-36ts mutant 33G-
D373-r36-ΔS35, which was disrupted for SUP35 and car-
ried the pRG415-SUP35 (URA3 SUP35) plasmid, allowed
the loss of the resident plasmid on 5-FOA-containing
medium at permissive temperature (Fig. 4), but did not
cause resistance to 37°C. Thus, the compensatory muta-
Cell morphology defects of the sup45 mutants incubated at 37°C Figure 3
Cell morphology defects of the sup45 mutants incubated at 37°C. The strain 33G-D373-ΔS45 disrupted for SUP45 and bearing 
the plasmids pRS315-sup45-sl23 (sup45-sl23), pRS315-sup45-36 (sup45-36) or pRS315-SUP45 (SUP45), was grown in liquid 
YPD medium for 15 h at 37°C. Bar = 6 μm.BMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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tions suppressed lethality caused by the combination of
either sup45-sl23ts or sup45-36ts with SUP35-C, but did not
suppress temperature sensitivity of sup45-36ts.
Synthetic lethality between sup45-sl23ts or sup45-36ts and 
SUP35-C is not caused by the increased levels of nonsense 
codon readthrough
We also tested, whether the SUP35-C compensatory muta-
tions influenced the nonsense codon readthrough caused
by the sup45-sl23ts and sup45-36ts mutations. For this, the
strain 33G-D373-rSL23 carrying the chromosomal sup45-
sl23ts mutation and wild type SUP35, was transformed
with centromeric plasmids containing either the SUP35-C
allele (control) or alleles with the SUP35-C14, SUP35-C11
or SUP35-C42 compensatory mutations along with either
one of the pUKC815, 817, 818, 819 plasmids. Quantita-
tive assay demonstrated that the nonsense codon
readthrough was noticeably decreased only in the pres-
ence of SUP35-C11. This compensatory mutation also
decreased the levels of nonsense readthrough in the
sup45-36ts  mutant 33G-D373-r36 carrying wild type
SUP35 but to a lesser extent than in the isogenic sup45-
sl23ts mutant 33G-D373-rSL23 (Fig. 5). Thus, though the
effect of SUP35-C compensatory mutations on the levels
of nonsense readthrough was not significant in most
cases, they all abolished synthetic lethality, making
unlikely that the increased levels of readthrough was the
reason of lethal interaction between the sup45ts mutations
and SUP35-C allele.
To confirm this we have constructed the strains 33G-
D373-rSL23-r35C and 33G-D373-r36-r35C, which car-
ried, respectively, the sup45-sl23ts and sup45-36ts mutations
and the SUP35-C  allele, as well as the centromeric
pCM183-SUP45 plasmid with the TRP1 selectable marker
and SUP45  under the control of regulatable tetO2 pro-
moter. The synthetic lethality of sup45ts  and  SUP35-C
combination in these strains was manifested only upon
the repression of wild type SUP45 by doxycycline. As a
control we used the isogenic strains 33G-D373-rSL23 and
33G-D373-r36, which had the wild type SUP35  gene
instead of the SUP35-C allele. To monitor the levels of
nonsense codon readthrough upon the repression of wild
type SUP45, all strains were transformed with either one
of the pUKC815, 817, 818, 819 plasmids.
Since chromosomally-encoded mutant eRF1 and its wild
type counterpart encoded by the plasmid were electro-
phoretically indistinguishable, we could not estimate a
decline in the amount of eRF1 upon the repression of the
plasmid  SUP45  in the studied strains. However, in
another strain with the same tetO2-SUP45 plasmid, 17 h
repression decreased the amount of eRF1 to approxi-
mately 5% of its initial levels. Importantly, this drop in
wild type eRF1 amount was accompanied with enrich-
ment of cultures with dead cells up to 20% for the 33G-
D373-rSL23-r35C and 33G-D373-r36-r35C strains, while
the number of such cells in the 33G-D373-rSL23 and
33G-D373-r36 cultures was less than 10%. The in vivo
quantification of UAA, UAG, and UGA nonsense
readthrough has shown that its levels in the strains with
synthetic lethal mutations was not higher than in the con-
trol strains (Fig. 6). This disagrees with the assumption
that the cause of synthetic lethality between sup45 muta-
tions and SUP35-C allele is too high levels of nonsense
codon readthrough. Incubation of the strain 33G-D373-
rSL23-r35C carrying the tetO2-SUP45 plasmid in medium
containing doxycycline did not cause any change in the
polyribosome content or distribution (data not shown),
indicating absence of the sharp effect on translation.
Discussion
Here, we have demonstrated that the sup45-sl23ts muta-
tion did not decrease the levels of eRF1, and sup45-sl23ts
extra copies neither suppressed synthetic lethality, nor
decreased nonsense codon readthrough. This indicates
that both defect of translation termination and lethal
interaction between sup45-sl23ts and SUP35-C  were not
due to a shortage of eRF1, making improbable suggestion
Compensatory mutations in plasmid SUP35-C restore viability  of the strain carrying the sup45-36ts and SUP35-C alleles Figure 4
Compensatory mutations in plasmid SUP35-C restore viability 
of the strain carrying the sup45-36ts and SUP35-C alleles. The 
sup45-36ts mutant 33G-D373-r36-ΔS35 disrupted for SUP35 
and carrying the SUP35 URA3 pRS316-SUP35 plasmid was 
transformed with either one of the LEU2 plasmids pRS315-
SUP35 (SUP35), pRS315-SUP35C (SUP35-C), pRS315-SUP35-
C11 (SUP35-C11), pRS315-SUP35-C14 (SUP35-C14), 
pRS315-SUP35-C42 (SUP35-C42) or pRS315 (empty vector). 
Transformants were incubated on 5FOA-containing medium 
for 3 days.BMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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that these effects were due to inefficient recycling of
mutant eRF1 by eRF3 lacking the N-terminal region. Fur-
thermore, such suggestion contradicts to our previous
data indicating that the NM region of eRF3 may negatively
affect its ability to recycle eRF1. It was shown that shortage
of eRF1 in the strain expressing full length eRF3 resulted
in higher levels of nonsense codon readthrough than in
the strain expressing eRF3C [14], while deletion of the
eRF3 NM region did not affect nonsense readthrough at
the normal levels of eRF1 [examined in the presence of the
tRNA suppressor SUP16 (SUQ5) to enable detection of a
decrease in nonsense readthrough levels; our unpublished
data]. This suggests that the presence of eRF3 NM region
has a significant negative effect on translation termination
only at the decreased eRF1 levels. Deficiency in eRF1
should make its recycling important for translation termi-
nation and, therefore, these data agreed with the hypoth-
esis that eRF3 is involved in the recycling of eRF1 and
indicated that NM region of eRF3 interferes with this proc-
ess. Thus, deletion of NM region should enhance the eRF3
activity, making improbable that the reason of synthetic
lethal interaction between SUP35-C  and  sup45-sl23ts or
sup45-36ts lies in inefficient translation termination. Fur-
thermore, the results of this work suggest that combina-
tion of SUP35-C with either sup45-sl23ts or sup45-36ts is
lethal not due to an increase of nonsense codon
readthrough.
The obtained SUP35-C mutations compensate for the lack
of the eRF3 N-terminal region, thus ruling out the possi-
bility that synthetic lethality was due to a disruption of
interaction with proteins that bind to this eRF3 region,
including interaction with the poly(A)+-binding protein
PABP [18,19]. This makes unlikely that synthetic lethality
was caused by a disturbance in regulation of mRNA decay
or by alteration of translation initiation by its uncoupling
Influence of the compensatory mutations in SUP35-C on the levels of nonsense codon readthrough in the sup45-sl23ts 33G- D373-rSL23 (A) and sup45-36ts 33G-D373-r36 (B) mutants Figure 5
Influence of the compensatory mutations in SUP35-C on the levels of nonsense codon readthrough in the sup45-sl23ts 33G-
D373-rSL23 (A) and sup45-36ts 33G-D373-r36 (B) mutants. Plasmids: SUP35-C, pRS315-SUP35C; SUP35-C11, pRS315-
SUP35C11; SUP35-C14, pRS315-SUP35C14; SUP35-C42, pRS315-SUP35C42. Suppression efficiency (average from three inde-
pendent transformants, each in three parallels) was estimated with the use of the pUKC815, 817, 818, 819 plasmids.BMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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Interaction between the sup45ts and SUP35-C alleles does not result in increase of the efficiency of nonsense codon  readthrough Figure 6
Interaction between the sup45ts and SUP35-C alleles does not result in increase of the efficiency of nonsense codon 
readthrough. Data for the 33G-D373-rSL23 (sup45-sl23ts SUP35) and 33G-D373-rSL23-r35C (sup45-sl23ts SUP35-C) strains (A), 
as well as for 33G-D373-r36 (sup45-36ts SUP35) and 33G-D373-r36-r35C (sup45-36ts SUP35-C) strains (B) are presented. All 
strains carrying the pCM183-SUP45 plasmid (tetO2-SUP45) were transformed with either one of the pUKC815, 817, 818, 819 
plasmids and grown in tryptophane omission medium to mid log phase. Then the cells were collected, resuspended in analo-
gous medium containing 10 μg/ml doxycycline. After 17 h of incubation in this medium, appropriate aliquots of yeast culture 
were taken and β-galactosidase activity was assayed. All data represent an average of at least three independent experiments.BMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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from termination. The latter is also supported by the
observation that synthetic lethality was not accompanied
by noticeable alteration of the polyribosomal profile.
Both identified sup45 mutations, sup45-sl23ts and sup45-
36ts, that make the N-terminal region of eRF3 indispensa-
ble, altered the N domain of eRF1 and, furthermore, they
caused substitutions of amino acids located in proximity
to each other. Both sup45-sl23ts and sup45-36ts increased
the levels of nonsense codon readthrough and, therefore,
affected translation termination. In addition, they did not
allow yeast cells to grow at 37°C. Earlier it was found that
temperature sensitivity of the sup45-36ts mutant was not
due to a defect of translation termination. Inability to
grow at non-permissive temperature was caused by the
impairment of cytokinesis resulting from mislocalization
of the eRF1-binding protein, myosin light chain Mlc1p
[25]. Though cytokinesis defect was not shown for the
sup45-sl23ts mutant, its temperature sensitivity also was
not caused by a defect in translation termination, suggest-
ing that yeast eRF1 may have different functions outside
of translation. It is also important that the compensatory
SUP35-C mutations alleviated both effects of the sup45-
sl23ts  mutation, temperature sensitivity and increased
nonsense readthrough, indicating that interaction with
eRF3 probably is important for eRF1 not only for promot-
ing translation termination, but also for its uncharacter-
ized function. In contrast, interaction with eRF3 is not
required for function of eRF1 in cytokinesis, since eRF1 in
a complex with Mlc1p can not bind eRF3 [25].
Conclusion
The data presented here show that the effect of synthetic
lethality can not be deduced from a defect of translation
termination. The study of the SUP35-C  compensatory
mutations has shown that they are able to suppress both
temperature sensitivity of sup45-sl23ts and its lethal inter-
action with SUP35-C. However, temperature sensitivity of
sup45-sl23ts and its synthetic lethality with SUP35-C are
caused by different reasons, since increasing the copy-
number of sup45-sl23ts alleviated temperature sensitivity
but did not abolish synthetic lethality. Therefore, these
data show that the eRF1/eRF3 complex may be involved
in different processes outside of translation termination.
In many yeast species the N-terminal part of the eRF3
release factors is responsible for their prion properties [29-
33]. Such conservation suggests that the prion properties
of yeast eRF3 have biological significance. In this work we
have shown that the prion-forming domain of eRF3 from
the yeast S. cerevisiae is important for its functioning out-
side of translation termination. However, this does not
mean that the N-terminal extension of eRF3 factors from
other organisms plays a similar role. Indeed, point muta-
tions altering S. cerevisiae eRF3C can compensate for the
lack of its NM region indicating that the C domain of eRF3
from other organisms may contain all information
required for this function.
Methods
Media and strains
Yeast strains were grown on standard organic (YPD) and
synthetic (SD) media [34]. The modified YPD media
(YPDm) [2% peptone, 0.5% yeast extract (Oxoid), 3%
glucose and 2% agar] was used in colony color sectoring
assay experiments, because it favored accumulation of red
pigment in the ade2  mutants. The 5-fluoroorotic acid
(5FOA) medium was prepared as described [35]. The
expression of the tetO2-controlled SUP45 was repressed by
incubation of corresponding strains on medium which
contained 10 μg/ml doxycycline and was selective for the
pCM183-SUP45 plasmid. LB and 2 × YT media were used
for bacteria [36]. Appropriate amounts of antibiotics,
amino acids, and bases were added when necessary. Yeast
cells were grown at 30°C, if not indicated otherwise, and
bacteria at 37°C. DNA transformation of lithium acetate-
treated yeast cells was performed as described previously
[37].  E. coli cells were transformed by the method
described in [38].
The E. coli mutator strain XL1-Red [endA1 gyrA96 thi-1
hsdR17 supE44 relA1 lac mutD5 mutS mutT Tn10 (Tetr)]
(Stratagene) was used for obtaining mutations in the plas-
mid SUP35-C gene. For this, the plasmid pRS315-SUP35C
was introduced into this E. coli strain. After incubation for
48 h, over 500 transformant colonies were suspended in
10 ml of 2 × YT supplemented with ampicillin (100 μg ml-
1). Cell culture was additionally incubated for 8 h with
shaking, plasmid DNA was isolated and used to transform
yeast. The E. coli strain DH5α [supE44 Dlac U169 (f80
lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1] [36]
was used in cloning experiments.
The yeast strains used are listed along with their genotypes
in Table 1. Construction of strains obtained in this study
is described below. The strain YJV159-rS35C, which con-
tains the 5'-deletion SUP35-C allele (encoding the eRF3
fragment lacking amino acids 1-253, eRF3C) in place of
the wild-type SUP35 allele, was obtained as follows. The
pFL44-SUP35C integrative plasmid [8] bearing the
SUP35-C allele was linearized by SalI site internal to the
SUP35 coding sequence and integrated into the SUP35
gene of the strain YJV159 by selecting transformants on
uracil omission medium. The Ura+ integrants expressing
both eRF3 and eRF3C were obtained and placed onto
5FOA-containing medium to select for plasmid excision.
The obtained Ura- clones were screened by Western blot-
ting to select strains expressing eRF3C only. Replacement
of SUP35 with SUP35-C was further confirmed by South-
ern analysis. The same integration/excision method wasBMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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used to obtain the temperature-sensitive sup45 mutants
33G-D373-rSL23 (sup45-sl23ts) and 33G-D373-r36
(sup45-36ts). The integrative plasmids pJJ244-sup45-sl23
and pJJ244-sup45-36 bearing the sup45-sl23ts and sup45-
36ts alleles, respectively, were linearized by MscI and inte-
grated into the chromosomal SUP45 gene of the strain
33G-D373. The obtained Ura+ transformants were placed
on 5FOA-containing medium for plasmid excision and
Ura- clones with the suppressor (growth on tryptophane
and histidine omission media) and temperature sensitive
(inability to grow on YPD at 37°C) phenotypes were
selected. Then, the obtained strains 33G-D373-rSL23 and
33G-D373-r36 were disrupted for SUP35 to obtain respec-
tively the strains 33G-D373-rSL23-ΔS35 and 33G-D373-
r36-ΔS35. To perform this, the XhoI-Ppu10I DNA frag-
ment of the plasmid pSUP35::TRP1 was used to transform
the strains 33G-D373-rSL23 and 33G-D373-r36 harbor-
ing the pRS316-SUP35 (SUP35 URA3) plasmid. The
clones unable to grow on 5FOA plates (without pRS316-
SUP35) were selected. Disruption of SUP35  in these
strains was confirmed by PCR analysis. The strains 33G-
D373-rSL23-rS35C (sup45-sl23tsSUP35-C) and 33G-
D373-r36-rS35C (sup45-36tsSUP35-C) were constructed
in the same way as YJV159-rS35C. However, the pRS315-
SUP45 (SUP45 LEU2) plasmid was introduced into the
33G-D373-rSL23 and 33G-D373-r36 strains before the
integration/excision procedure to prevent synthetic
lethality of the sup45ts and SUP35-C alleles. The pRS315-
SUP45 plasmid was then replaced with the pCM183-
SUP45 (tetO2-SUP45 TRP1) plasmid.
Plasmids
The plasmids used are listed along with their essential
characteristics in Table 2. The pRS315-SUP35, pRS316-
SUP35, pHT-SUP35 and pSUP35::TRP1 plasmids were
constructed as follows. The SUP35-containing XhoI-XbaI
DNA fragment of the plasmid pEMBLyex4-SUP35 [8] was
inserted into the XbaI-SalI sites of pRS315, pRS316, pET-
30a(+) (Novagen) and pBluescript II KS(+) (Stratagene)
vectors giving the plasmids pRS315-SUP35, pRS316-
SUP35, pET-S35 and pBS-SUP35, respectively. Next, the
XbaI-NotI DNA fragment of pET-S35 containing SUP35
was cloned into the same sites of the centromeric ADE3
URA3 vector pHT4467 [39] resulting in pHT-SUP35. The
TRP1-containing Acc65I-BglII DNA fragment of the pJJ281
plasmid [40] was cloned into the BsrGI and BclI sites of
pBS-SUP35.  HpaI-HpaI DNA fragment of the resulting
plasmid was deleted, and thus, the plasmid
pSUP35::TRP1 used for disruption of the chromosomal
SUP35 gene was constructed. The MluI/Klenow-XbaI DNA
fragment of the plasmid pEMBLyex4-SUP35C containing
the 5'-deletion SUP35-C allele [8] was inserted between
the SmaI and XbaI sites of pRS315 and as a result the plas-
mid pRS315-SUP35C was obtained. The plasmid pRS315-
SUP35MC was constructed by the insertion of PvuII-XbaI
DNA fragment of pEMBLyex4-SUP35MC [8] which con-
tained the mutant SUP35-MC allele encoding eRF3 with-
out the N domain into the SmaI and XbaI sites of pRS315.
Mutant alleles SUP35-C11, SUP35-C14 and SUP35-C42,
cloned into the shuttle vector pRS315, were sequenced
using a set of primers specific for SUP35.
The SUP45 gene was cloned using a yeast genomic library
based on the plasmid p366, which was identical to YCp50
[41], but had LEU2 instead of URA3 (gift of P. Hieter). Iso-
lation and sequencing of the sup45-sl23ts  allele was
described earlier [25]. The plasmid YEplac181-sup45-sl23
was obtained by insertion of the XbaI-XhoI DNA fragment
of pRS315-sup45-sl23 containing the mutant sup45-sl23ts
allele into the XbaI and SalI sites of YEplac181. The XhoI-
SacI DNA fragments carrying the sup45 mutant alleles of
the plasmids pRS315-sup45-36 and pRS315-sup45-sl23
were cloned between the SalI and SacI sites of the integra-
tive  URA3  vector pJJ244 [40] to obtain the plasmids
Table 1: S cerevisiae strains used in this study
Strain Genotype Source/
reference
YJV159 MATa ade2 ade3 his3 leu2-3,112 trp1 ura3 [46]
YJV159-rS35C Same as in YJV159, but with SUP35-C instead of SUP35 This study
YJV159-rS35C-SL23 Same as in YJV159-rS35C, but with sup45-sl23ts instead of SUP45 This study
33G-D373 MATa ura3-52 leu2-3 112 trp1-289 his7-1 lys9-A21 pheA10 ade2-144, 717 [47]
33G-D373-rSL23 Same as in 33G-D373, but with sup45-sl23ts instead of SUP45 This study
33G-D373-rSL23-rS35C Same as 33G-D373-rSL23 but with SUP35-C instead of SUP35 This study
33G-D373-r36 Same as in 33G-D373, but with sup45-36ts instead of SUP45 This study
33G-D373-r36-rS35C Same as 33G-D373-r36 but with SUP35-C instead of SUP35 This study
33G-D373-rSL23-ΔS35 Same as in 33G-D373-rSL23, but with sup35::TRP1 This study
33G-D373-r36-ΔS35 Same as in 33G-D373-r36, but with sup35::TRP1 This study
33G-D373-ΔS45 Same as in 33G-D373, but with sup45::ADE2 [25]
S1-H8 MATa leu2-3,112 his3-Δ1 ura3-52 trp1-289 sup45::TRP1 [14]
S1-R-H8 Same as in s1-H8, but with SUP35-C instead of SUP35 [14]
his7-1 and lys9-A21 and ade2-1, ochre mutations, trp1-289, amber mutation.BMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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pJJ244-sup45-36 and pJJ244-sup45-sl23, respectively. The
pCM183-SUP45 plasmid bearing the SUP45 gene under
the control of regulatable tetO2 promoter was constructed
as follows. Using the plasmid pRS315-SUP45 as template,
PCR was applied to place the NcoI site (CCATGG) at the
SUP45  translation initiation codon. The obtained PCR
fragment was digested with NcoI and XhoI and cloned into
the same sites of the E. coli plasmid pET-30a(+) (Nova-
gen) to generate the plasmid pL51-3. The KpnI-XhoI frag-
ment of pL51-3, containing the coding sequence of
SUP45, was inserted into the KpnI and SalI sites of
YEplac112 resulting in the YEplac112-atgSUP45 plasmid.
Then, the EcoICRI-PstI fragment of YEplac112-atgSUP45
was cloned into the HpaI and PstI sites of pCM183 [42].
β-galactosidase activity in cell lysates was quantified as
described [43]. The levels of UAA, UAG and UGA
readthrough were determined using the pUKC815/817/
818/819 series vectors, as described previously [44].
Colony color sectoring assay
The assay is based on the facts that ade2 yeast cells accu-
mulate a red pigment and form red colonies but ade2 ade3
cells do not accumulate this pigment and, consequently,
form white colonies because the ade3 mutation blocks the
pathway at a point prior to the accumulation of the pig-
ment [45]. Thus, a strain that is ade2 ade3, but carries
ADE3 on an autonomously replicating plasmid, forms on
medium non-selective for this plasmid red colonies (cells
with the plasmid) that contain white sectors (cells that
have lost the plasmid). We refer this phenotype as Sect+
(ability to lose the ADE3 plasmid), and, consequently, the
phenotype of red clones without white sectors or with a
negligible number of such sectors is Sect- (inability to lose
the ADE3 plasmid). Multiple suspensions of the SUP35-C
ade2 ade3 strain YJV159-rS35C carrying the centromeric
plasmid pHT-SUP35 (SUP35 ADE3) were prepared in liq-
uid uracil omission medium; each suspension deriving
from a separate colony grown on uracil omission medium
was diluted, and plated on ten YPDm plates at approxi-
mately 5,000 cells per plate. These cells were mutagenized
with UV irradiation to approximately 10% survival and
then incubated for 4 or 5 days. As expected, most clones
were Sect+. Cells from Sect- colonies were streaked on
YPDm and after 2 days, individual colonies were
restreaked on YPDm. Only strains that continued to give
red colonies or red colonies with rare white sectors were
studied further.
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Table 2: Plasmids used in this study
Plasmid Characteristics Source/reference
YEplac181 Multicopy LEU2 vector [48]
pRS315 Centromeric LEU2 vector [49]
pRS316 Centromeric URA3 vector [49]
pRG415-SUP45 Centromeric URA3 vector with SUP45 [14]
pRS315-SUP45 Same as pRS315, but with SUP45 [25]
pRS315-sup45-36 Same as pRS315, but with the sup45-36ts mutant allele [25]
pRS315-sup45-sl23 Same as pRS315, but with the sup45-sl23ts mutant allele [25]
YEplac181-sup45-sl23 Same as YEplac181, but the sup45-sl23ts mutant allele This study
pRS315-SUP35 Same as pRS315, but with SUP35 This study
pRS315-SUP35-C11 Same as pRS315, but with SUP35-C11 This study
pRS315-SUP35-C14 Same as pRS315, but with SUP35-C14 This study
pRS315-SUP35-C42 Same as pRS315, but with SUP35-C42 This study
pRS316-SUP35 Same as pRS316, but with SUP35 This study
pFL44-SUP35C Integrative URA3 vector with SUP35-C [8]
pSUP35::TRP1 Integrative vector with the sup35::TRP1 disruption allele This study
pHT-SUP35 Centromeric ADE3 URA3 vector containing SUP35 This study
pRS315-SUP35C Same as pRS315, but with SUP35-C This study
pRS315-SUP35MC Same as pRS315, but with SUP35-MC This study
pJJ244-sup45-sl23 Integrative URA3 vector with the sup45-sl23ts allele This study
pJJ244-sup45-36 Integrative URA3 vector with the sup45-36ts allele This study
pCM183-SUP45 Centromeric TRP1 vector containing SUP45 under the control of regulatable tetO2 promoter This studyBMC Molecular Biology 2006, 7:34 http://www.biomedcentral.com/1471-2199/7/34
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